Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nexstim OyjFRA:5NX +6.07%69 PB Ratio is 8.38 as of Sep. 07, 2026, which is 29% above its 10-year median of 6.49. GuruFocus rates FRA:5NX with a GF Score™ of 69/100 and a GF Value™ of €9.65 (Fairly Valued). The stock has 5 warning signs investors should review. Among 783 Medical Devices & Instruments companies, Nexstim Oyj ranks worse than 89.91% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-09-07), Nexstim Oyj's share price is €9.78. Nexstim Oyj's Book Value per Share for the quarter that ended in Jun. 2026 was €1.17. Hence, Nexstim Oyj's PB Ratio of today is 8.38.
Good Sign:
Nexstim Oyj stock PB Ratio (=9.25) is close to 2-year low of 8.83.
The historical rank and industry rank for Nexstim Oyj's PB Ratio or its related term are showing as below:
FRA:5NX'
s PB Ratio Range Over the Past 10 Years
Min: 0.3 Med: 6.49 Max: 29.98
Current: 9.25
During the past 13 years, Nexstim Oyj's highest PB Ratio was 29.98. The lowest was 0.30. And the median was 6.49.
FRA:5NX's PB Ratio is ranked worse than 89.91% of 783
companies
in the Medical Devices & Instruments industry
Industry Median: 2.17
vs FRA:5NX: 9.25
During the past 12 months, Nexstim Oyj's average Book Value Per Share Growth Rate was 163.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -1.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Nexstim Oyj was 89.50% per year. The lowest was -63.40% per year. And the median was 0.55% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Nexstim Oyj PB Ratio Related Terms
Nexstim Oyj PB Ratio Historical Data
* Premium members only.
The historical data trend for Nexstim Oyj's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nexstim Oyj's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexstim Oyj PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nexstim Oyj's PB Ratio distribution charts can be found below:
* The bar in red indicates where Nexstim Oyj's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Nexstim Oyj's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Nexstim Oyj (FRA:5NX) has a PB Ratio of 8.38 as of Sep. 07, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Nexstim Oyj and its competitors. This is 29% above median its historical median of 6.49. Over the past decade, Nexstim Oyj's PB Ratio has ranged from 0.30 to 29.98. According to the industry distribution chart, Nexstim Oyj ranks #704 out of 783 companies in the Medical Devices & Instruments industry, placing it in the top 89.9%.
Is Nexstim Oyj's PB Ratio too high?
Nexstim Oyj's current PB Ratio of 8.38 is 29% above median its 10-year median of 6.49. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 29.98. The Medical Devices & Instruments industry median PB Ratio is 2.17. Nexstim Oyj's value of 8.38 is 286.2% above this industry median. Based on the distribution chart, Nexstim Oyj ranks #704 out of 783 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Nexstim Oyj has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nexstim Oyj's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nexstim Oyj ranks #704 out of 783 companies for PB Ratio. This places Nexstim Oyj in the lower half of its industry. The industry median PB Ratio is 2.17. Nexstim Oyj's value of 8.38 is 286.2% above this benchmark. Historically, Nexstim Oyj's own PB Ratio has ranged from 0.30 to 29.98 over the past decade. While the company's 10-year median is 6.49 vs. the industry median of 2.17, Nexstim Oyj has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.17, based on 783 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nexstim Oyj's current PB Ratio of 8.38 is 286.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Nexstim Oyj and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexstim Oyj's current PB Ratio is 8.38, which is 29% above median its own 10-year median of 6.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexstim Oyj stock overvalued right now?
Based on GuruFocus' analysis, Nexstim Oyj (FRA:5NX) is currently considered Fairly Valued. The stock's GF Value™ is €9.65, compared to a current price of €9.78 — trading 1.3% above its estimated fair value. The current PB Ratio is 8.38, which is 29% above median its 10-year median of 6.49 and 286.2% above the Medical Devices & Instruments industry median of 2.17. Nexstim Oyj's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Nexstim Oyj (FRA:5NX), the current PB Ratio is 8.38 as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexstim Oyj (FRA:5NX) Overvalued in 2026?
Based on GuruFocus' analysis, Nexstim Oyj stock appears to be overvalued.
The current stock price of €9.78 is trading 1.3% above its estimated GF Value™ of €9.65.
GuruFocus considers Nexstim Oyj to be Fairly Valued.
Key valuation signals for FRA:5NX:
PB Ratio: 8.38 (29% above median its 10-year median of 6.49)
GF Value™: €9.65 vs. price of €9.78 (1.3% above fair value)
Industry Position: 286.2% above the Medical Devices & Instruments median (#704 of 783)
No single metric tells the full story. See the FRA:5NX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexstim Oyj is a Finnish medical technology company. It has developed a non-invasive brain-stimulation technology for navigated transcranial magnetic stimulation (nTMS), with sophisticated 3D navigation that provides accurate, personalized targeting of TMS to specific brain areas. The company's diagnostic business focuses on commercializing the NBS System 6, an FDA-cleared, CE-marked navigated TMS system for pre-surgical mapping of the brain's speech and motor cortices. Its therapy business sells the NBS System 6 for the treatment of depressive disorder in the United States, and for the treatment of depression, chronic neuropathic pain, and post-operative rehabilitation of motor deficits of the upper limb, in Europe. Geographically, the firm generates maximum revenue from North America.
69GF Score
Get the complete analysis for FRA:5NX
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5NX has been successfully added to your 
